E xtrapleural pneumonectomy has been used in the treatment
|
|
|
- Colin Marsh
- 10 years ago
- Views:
Transcription
1 Extrapleural Pneumonectomy in the Setting of a Multimodality Approach to Malignant Mesothelioma* David I. Sugarbaker, M.D., F.C.C.P; StevenJ. Mentzei M.D., F.C.C.P; Malcolm DeCamp, M.D.; Thomas j Ljnch, Jr., M.D.; and Gary M. Strauss, M.D. The use ofextrapleural pneumonectomy in a multimodality treatment setting for malignant pleural mesothelioma is described, presenting first the right-sided approach and then the left-sided. This technique used in a multimodality approach with CAP chemotherapy (cyclophosphamide 600 mg/rn, doxorubicin 60 mg/rn2, cisplatin 75 mg/rn2) 5 cycles at 3-week intervals, and radiotherapy (55 Gy radiation to sites of previous bulky disease or residual disease) to treat 44 patients with malignant pleural mesothelioma resulted in improved operative mortality and decreased length of hospital stay. (Chest 1993; 103: ) E xtrapleural pneumonectomy has been used in the treatment of tuberculous empyema 3 and other pleural diseases including malignant pleural mesothelioma (MPM).-b6 Its initial use in the treatment ofmpm reportedly resulted in relatively high operative mortality6 compared with standard ee 7 At our institution, we have gained significant experience over the past 8 years treating diffuse MPM with a protocol including pleuropneumonectomy, CAP (cyclophosphamide/ doxorubicin/cisplatin) chemotherapy, and radiotherapy. Treatment results from a series of 44 patients indicate an advantage to identifying patients preoperatively who may derive survival benefit from such aggressive procedures within a multimodality treatment protocol. Our surgical technique, which includes resecting the lung, parietal and visceral pleura, pericardium, and diaphragm, has evolved over the 8 years, and the associated operative mortality and length of hospital stay have continued to decrease. Our technique, which will be discussed, varies depending on whether it is performed on the right or the left side, and differs from extrapleural pneumonectomy techniques described elsewhere 918 Patient Selection PATIENTS AND METHODS We base selection of patients for our procedure on the traditional parameters for defining operability in pneumonectomy patients. It is helpful to use forced expiratory volume in 1 second (FEy,) as well as other dynamic spirometry testing and functional oximetry in patient selection. In the case ofborderline patient eligibility, the use of quantitative ventilation perfusion scanning may be of significant benefit for predicting postoperative pulmonary function. *Fmm the Harvard Medical School (Dr. Lynch) and the Division of Thoracic Surgery (Drs. Sugarbaker, Mentzer, and DeCamp), and Department of Medicine (Dr. Strauss), Brigham and Women s Hospital, Boston. Reprint requests: Dr. Sugarbaker, Brigham & Women Hospital, 75 Francis Street, Boston Because patients ultimately receive doxorubicin as adjuvant chemotherap); we use preoperative echocardiography to define ventricular function. We have found the echocardiogram to be helpful in identifying patients who ll be able to tolerate not only the pneumonectomy but also the postoperative adjuvant treatments. Midway through the postoperative chemotherapy course, the baseline echocardiogram is used again to detect possible cardiac toxicity Preoperative chest magnetic resonance imaging (MRI) scanning has been useful for determining the extent of disease and particularlv for visualization of the sagittal planes, demonstrating evidence ofdisease in the paravertebral sulcus or disease extending through the diaphragm. Sagittal cuts also are significantly helpful for predicting mediastinal involvement of the cava, esophagus, or trachea; operative resection is precluded by any one of these findings. In cases where transdiaphragmatic involvement is suspeeted but not proven, limited laparotomy is used to inspect the liver for determination of actual invasion. Routine preoperative echocardiography and M RI are extremely helpful in decreasing the number of patients for whom resection is precluded at the time of surgical exploration. Patients Between 1980 and 1991, 44 patients were selected and enrolled in a protocol involving extrapleural pneumonectomy used as a means of control of the primary tumor. Participants included 35 men and 9 women, with a median age of54 years (range, 46 to 62). We perform resection only on patients with Butchart clinical stages I and II disease, and all study subjects in this trial were judged bs clinical preoperative criteria to have Butchart s stage I pleural MPM6 (tumor confined within the capsule of the parietal pleiira, 1#{128}, involving only ipsilateral lung, pericardium, and diaphragm, and thout regional node involvement). The treatment protocol used at the Brigham and Women s Hospital consisted of extrapleural pneumonectomy, including resection of pericardium and diaphragm, followed by CAP chemotherapy employing cyclophosphamide 600 mg/m2, doxorubicin 60 mg/m2, and cisplatin 75 mg/m2. Five chemotherapy cycles were given at 3-week intervals, followed in turn by 55 Gy radiation to previous sites of bulky disease or to sites of residual disease in the ipsilateral chest. At present, other adjuvant chemotherapy protocols are being developed in the United States and Europe. 2 Every attempt was made for as complete a cytoreductive procedure as possible, although clean surgical margins have not been shown to be beneficial in predicting survivors of MPM. 6 SUR(;ICAL TEChNIQuE An extended right thoracotomv along the course of the 6th rib is the incision for right-sided pleuropneumonectomy (Fig 1)! The incision is extended from the posteru)r aspect of the thorax, beginning midway between the posterior scapular ridge and the spine. The cut is carried along the bed of the 6th rib to the costochondral junction. At this juncture, a subperiosteal resection of the 6th rib is performed to create wider exposure and facilitate entrance into the extrapleural plane. The periosteum is then CHEST / 103 / 4 I APRIL, 1993 / Supplement 377$
2 reflection FIGURE 3. Dissection of the pleural envelope off the diaphragm. FIGURE 1. The extended right thoracotomy incision. From Sugarbaker et al, with permission. opened, and a broad-based dissection is begun superiorly toward the apex, using blunt and sharp techniques. The dissection is completed along the anterior lateral aspect superiorly and then begun in a similar fashion inferiorly and laterally to the diaphragm. We avoid dissection posteriorly to the azygous vein until wider exposure has been gained. Following placement of 2 chest retractors anteriorly and posteriorly, we continue blunt and sharp dissection up to the cupola of the lung. Care is taken to palpate the course of the subclavian artery and maintain the plane between the parietal pleura and these vessels. It also is important to preserve the internal mammary artery and vein, which often pass through the extrapleural plane superomedially. If mistaken for adhesions, these vessels can be avulsed from either the superior vena cava or the subclavian artery. Small adhesions are divided, staying close to the pleural plane in the extrapleural fat. Next, the dissection is performed immediately from the apex of the lung to the azygous vein. Dissection is continued extrapleurally until the right upper lobe and main stem bronchus are clearly identified (Fig 2). With sharp as well as blunt dissection, the cava and azygous vein are then dissected from the parietal pleural structures, again taking care to prevent avulsing the veins. The dissection is continued anteriorly and inferiorly to the circumferential diaphragmatic margin. The next step is placement of a nasogastnc tube, which facilitates Azygos vein Subclavian vessels Superior cava. Ce cc Right main bronchus / Peritoneum FIGURE 2. The right main stem bronchus identified. From Sugarbaker et al, with permission. FIGURE 4. The pentoneum wiped off the diaphragm with a sponge. 378$ Extrapleural Pneumonectomy in Malignant Mesothelioma (Sugarbaker eta!)
3 Pulmonary artery Diaphragm Parietal pleura Visceral pleura FIGURE 5. Diaphragm and pleural envelope divided lateral to inferior cava and esophagus. pal pation of the esophagus to preserve it from damage. The diaphragm is then opened posterolaterally in a radial fashion to the anterior medial aspect of the pericardium. We are careful to keep the pleural envelope intact, which, in some cases requires dissection of the pleural envelope off the diaphragm prior to its division (Fig 3). When dividing the diaphragm, care must be taken to preserve the underlying peritoneum. We use blunt dissection to wipe the peritoneum off the diaphragm, using a sponge stick (Fig 4). After the diaphragm has been divided anterolaterally to the pericardium, it is divided along the caval and esophageal hiatuses. To facilitate this dissection, one may enter the pericardium to define the course of the inferior vena cava through the diaphragm. The diaphragm and pleural envelope are then dissected just lateral to the inferior cava and esophagus (Fig 5), thereby completing removal of the diaphragm. At the next stage of the procedure, the pericardium is formally opened anteromedially to the phrenic nerve and the hilar vessels (Fig 6). At this point, care is taken to keep the panetal pleural FIGURE 7. The intrapericardial right pulmonary artery divided by two staple lines. envelope intact. The main pulmonary artery is divided free from the cava and underlying superior pulmonary vein, using two staple lines to divide the intrapericardial right pulmonary artery (Fig 7).22 After the pulmonary artery has been divided, the superior pulmonary veins are divided in the same manner. Next, the pericardium is divided posterior to the hilum, thereby completing the pericardial resection. The specimen is then elevated, and dissection continues posterior to the pericardium and lateral to the esophagus. Subcarinal node dissection is performed, and the main bronchus is dissected to the carina. It is stapled with a heavy gauge bronchial stapler (Fig 8),u and the specimen is removed. A pericardial fat pad is then raised into place over the bronchial stump, and the pericardium is closed with a prosthetic patch using a monofilament suture (Fig 9). In the right-sided procedure, the pericardium is always reconstructed to prevent the potentially fatal complication of cardiac herniation. Fenestrations are made in the patch to prevent tamponade. The next stage of the procedure is reconstruction of the diaphragm. We have found that the use of impermeable membranes welope enic I vessels nerve Pericardial incision Trachea._I::.:::: Stapler Right main bronchus 1 h i.riil FIGURE 6. The pericardium opened anteriorly, medial to the phrenic nerve and hilar vessels. From Sugarbaker et al,u with permission. FIGURE 8. The main bronchus dissected to the carina and stapled. CHEST / 103 I 4 / APRIL Supplement 379$
4 Fat pad Fenestrated patch FIGURE 9. A pericardial fat pad sewn to cover the bronchial stump; pericardium closed with a patch, and fenestratiorts made in the patch. From Sugarhaker et al, with permission. prevents rapid filling of the chest cavity by peritoneal fluid. Such rapid filling can produce mediastinal shift or tamponade in the early postoperative period, before mediastinal stabilization. If peritoneal covering remains intact after the dissection, multiple sutures of 0 vicryl are used in a reefing fashion (Fig 10) to provide strength to the overlying peritonetim. The sutures are anchored in the chest wall (Fig 10), and flo further reconstruction is needed. If, however, the peritoneum was not spared in the procedure, we place a prosthetic impermeable patch and sew it into place with a running monofilament 0 suture (Fig 11). Surgical specimens are assessed in the pathology suite for resection margins in multiple areas. An remaining gross disease, FIGURE 1 1. A prosthetic impermeable patch sewn into place where the peritoneum has been removed. From Sugarhaker et al, with permission. even if limited, is outlined with clips before wound closure for subsequent radiotherap The chest is then closed in multiple layers to assure watertight closure. A red rubber catheter is left in the chest until the skin is closed, and air (750 InI in women, 1,000 ml in men) is removed from the chest before the patient leaves the operating room. In the recover room, a chest x-ray is obtained and, ifthe mediastinum is midline, the catheter is removed. If a mediastinal shift is seen, air can be either instilled or removed to balance the mediastinum before removing the catheter. Alternatively, ifoozing is present, the chest tube can remain in place to waterseal overnight. The Left-Sided Procedure The approach for left-sided lesions is similar to that performed on the right side. Technically we find the left-sided procedure easier, due to the absence of the caval and esophageal hiatus. There are, however, subtle differences. Care must be taken to enter the correct plane in the preaortic region when dissecting the medial aspect of the specimen in the Cut edge of pericardium Pulmonary artery / Anchoring in chest wall suture Left lung FIGURE 10. Reconstruction of the diaphragm using multiple sutures of 0 vicryl in reefing fashion; the sutures are anchored to the chest wall. FIGURE 12. The pulmonary artery extrapericardial and extrapleural, read to be dissected. 380$ Extrapleural Pneumonectomy in Malignant Mesothelioma (Sugarbaker et a!)
5 posterior region. If an incorrect retroaortic plane is entered, bleeding will result from avulsion of the intercostal vessels. In addition, it is important that tumor involvement of the aorta be assessed at this time. Once the specimen has been circumferentially dissected from the chest wall, the diaphragm is divided along the left side in a radial fashion. Care must be taken to spare the aorta at the hiatus. The pericardium is then entered inferiorly, and the vessels are identified. In the left-sided procedure, unlike that used on the right, we prefer to dissect the extrapleural left main pulmonary artery as it leaves the pericardium and enters the left chest. Using two vascular staple lines, we divide the pulmonary artery in its extrapericardial, extrapleural position (Fig 12). The veins are taken from within the pericardium, and the pericardial resection is completed posteriorly. On the left side, the left main bronchus must be dissected for a greater distance to ensure a short bronchial stump. Just as in the right-sided procedure, the bronchial stump is covered, the diaphragm reconstructed, and the chest closed. The pericardium is not routinely reconstructed on the left side because the risk of cardiac herniation is low. At the end of the left-sided procedure, less air needs to be removed (500 ml in women, 750 ml in men). Hemostasis We encourage aggressive use of electrocautery because hemostasis is vital to successful completion ofextrapleural pneumonectomy. Following completion of dissection, rapid packing of areas also is undertaken. Following removal of the specimen, hemostatic sheets (Surgicel, Johnson & Johnson, Arlington, Tex) are placed over the raw chest-wall surface. Packs are then placed on them, and several minutes of tamponade is allowed to ensure a dry closure. CLINICAL RESULTS AND DISCUSSION The potential prognostic significance of various factors affecting patients with MPM were evaluated in a series of 44 consecutive patients undergoing multimodality protocol therapy between 1980 and Perioperative mortality was 4.6%, and morbidity was 30%. Survival of different patient groups was evaluated with Cox proportional hazards models. The following potential prognostic factors were not found to be statistically significant for survival: presence of gross residual tumor, microscopic tumor at the resection margin, tumor involving pericardium, and tumor involving diaphragm. These findings suggest that an aggressive multimodality regimen that includes pleural pneumonectomy can be accomplished with acceptable morbidity and mortality. Alternative treatment strategies, possibly involving neoadjuvant chemotherapy and/or intracavitary chemotherapy, could be considered in selected patients. Preoperative identification of patients with improved prognoses should aid in selecting patients for aggressive regimens and further define the role of multimodality therapy in MPM. REFERENCES 1 Hood RM, Antman K, Boyd A, et al. Surgical diseases of the pleura and chest wall. In: Pleural infections. Philadelphia: WB Saunders Co, 1986; Moran JF. Surgical treatment of pulmonary tuberculosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: WB Saunders Co, 1990; Sarot IA. Extrapleural pneumonectomy and pleurectomy in pulmonary tuberculosis. Thorax 1949; 4: Worn H. Moglichkeiten und Ergebnisse der chirurgischen Behandlung des malignen Pleuramesotheliomas. Thoraxchir Vask Chir 1974; 22: Bamler KJ, Maassen W. The percentage ofbenign and malignant pleura-tumors among the patients of a clinic of lung surgery with special consideration of the malignant pleuramesothelioma and its radical treatment, including results of a diaphragm substitution of preserved dura mater [Ger]. Thoraxchir Vask Chir 1974; 22: Butchart EG, Ashcroft T, Barnsley VC, et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 1976; 31: DeLaria GA, Jensik R, Faber LP, et al. Surgical management of malignant mesothelioma. Ann Thorac Surg 1978; 26: Butchart EG, Ashcroft T, Barnsley WC, et al. The role of surgery in diffuse malignant mesothelioma ofthe pleura. Semin Oncol 1981; 8: Faber LP Malignant pleural mesothelioma: operative treatment by extrapleural pneumonectomy. In: Kittle CF. ed. Current controversies in thoracic surgery. Philadelphia: WB Saunders Co, 1986; Antman KH, Shemin RJ, Corson JM. Malignant pleural mesothelioma: a combined modality approach. In: Kittle CF, ed. Current controversies in thoracic surgery. Philadelphia: WB Saunders Co, 1986; DaValle MJ, Faber LP, Kittle CF. et al. Extrapleural pneumonectomy for diffuse, malignant mesothelioma. Ann Thorac Surg 1986; 42: Falkson C, Alberts AS, Falkson HC. Malignant pleural mesothelioma treatment: the current state of the art. Cancer Treat Rev 1988; 15: Dogan R, Cetin C, Moldibi B, et al. Traitement chirurgical du mesotheliome pleural. Rev Pneumol Clin 1988; 44: Landa L, Fianchini A, Gesuelli GC, et al. II Ruolo della chirurgia nel trattamento del mesotelioma pleurico. Chir Ital 1989; 41: Harvey JC, Fleischman EH, Kagan R, et al. Malignant pleural mesothelioma: a survival study. J Surg Oncol 1990; 45: Sugarbaker DJ, Heher EC, Lee TH, et al. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1991; 102: Choi NC, Mathisen DJ, Huberman MS, et al. Cancer of the lung. In: Osteen RT, Cady B, Rosenthal PE, et al, eds. Cancer manual. 8th ed. Boston: American Cancer Society, Massachusetts Division Inc, 1990; Kittle CF. Pleural mesothelioma. In: Grillo HC, Austen WG, Wilkins EW Jr. et al, eds. Current therapy in cardiothoracic surgery Toronto: BC Decker mc, 1989; Antman K, Pass HI, Recht A. Benign and malignant mesothelioma. In: DeVita VTJr, Hellman 5, Rosenberg SA, eds. Cancer: principles and practice of oncology. 3rd ed. Philadelphia: JB Lippincott, 1989; Boutin C, Viallat JR. Astoul P Treatment of mesothelioma with interferon gamma and interleukin 2 [Fr]. Rev Pneumol Clin 1990; 46: Boutin C, Viallat JR, vanzandwijk N, et al. Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma. Cancer 1991; 67: Sugarbaker DJ, Mentzer SJ, Strauss C. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 1992; 54: Sugarbaker DJ, Mentzer SJ. Improved technique for hilar vascular stapling. Ann Thorac Surg 1992; 53: CHE5T / 1 03 I 4 / APRIL, / Supplement 381$
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,
Mesothelioma. Malignant Pleural Mesothelioma
Mesothelioma William G. Richards, PhD Brigham and Women s Hospital Malignant Pleural Mesothelioma 2,000-3,000 cases per year (USA) Increasing incidence Asbestos (50-80%, decreasing) 30-40 year latency
A Practical Guide to Advances in Staging and Treatment of NSCLC
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
Clinical Indications and Results Following Chest Wall Resection
Clinical Indications and Results Following Chest Wall Resection for Recurrent Malignant Pleural Mesothelioma Ali SO, Burt BM, Groth SS, DaSilva MC, Yeap BY, Richards WG, Baldini EH and Sugarbaker DJ. Division
Malignant Mesothelioma Current Approaches to a Difficult Problem. Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center
Malignant Mesothelioma Current Approaches to a Difficult Problem Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center Malignant Pleural Mesothelioma Clinical Presentation Insidious
بسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
Resection of Lung Cancer Invading the Mediastinum
Resection of Lung Cancer Invading the Mediastinum Philippe G. Dartevelle MARIE-LANNELONGUE HOSPITAL GUSTAVE ROUSSY INSTITUTE INSTITUTE OF THORACIC ONCOLOGY PARIS SUD UNIVERSITY Mediastinal Invasion Superior
Malignant pleural mesothelioma: outcome of limited surgical management
Interactive Cardiovascular and Thoracic Surgery 2 (2003) 30 34 Institutional review Thoracic general Malignant pleural mesothelioma: outcome of limited surgical management Peter G. Phillips a, George Asimakopoulos
Columbia University Mesothelioma Applied Research Foundation - 2009 - www.curemeso.org. Mesothelioma Center www.mesocenter.org
Columbia University Mesothelioma Center www.mesocenter.org Multimodal clinical trials, treatment (surgery, radiation, chemotherapy) Peritoneal mesothelioma program Immunotherapy translational, experimental
Proposed Adjustments to Pathologic Staging of Epithelial Malignant Pleural Mesothelioma Based on Analysis of 354 Cases
Original Article Proposed Adjustments to Pathologic Staging of Epithelial Malignant Pleural Mesothelioma Based on Analysis of 354 Cases William G. Richards, PhD 1,2 ; John J. Godleski, MD 2,3 ; Beow Y.
Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES LUNG SITE MESOTHELIOMA Lung Site Group Mesothelioma Date Guideline Created: April 2013 Authors: Dr. Meredith Giuliani, Dr. Andrea Bezjak 1.
Treating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
Malignant Mesothelioma
Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
Malignant Mesothelioma
Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
Sternotomy and removal of the tumor
Sternotomy and removal of the tumor All thymomas originate from epithelial thymic cells 4% of them consist of a pure population of epithelial cells Most have mixed populations of lymphoid cells to a
Photodynamic Therapy for Malignant Pleural Mesothelioma
S-75 Photodynamic Therapy for Malignant Pleural Mesothelioma Presented by Joseph S. Friedberg, MD, University of Pennsylvania Health System, Philadelphia, Pennsylvania Abstract Surgery is the treatment
Cardiac Masses and Tumors
Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:
Delayed Bronchial Stump Dehiscence Following Trimodality Treatment for Malignant Pleural Mesothelioma
Journal of the Egyptian Nat. Cancer Inst., Vol. 21, No. 3, September: 265-270, 2009 Delayed Bronchial Stump Dehiscence Following Trimodality Treatment for Malignant Pleural Mesothelioma ABDEL RAHMAN M.
Treatment of Malignant Pleural Mesothelioma: Is There a Benefit to Pleuropneumonectomy?
55 Treatment of Malignant Pleural Mesothelioma: Is There a Benefit to Pleuropneumonectomy? Stacey Su, Michael T. Jaklitsch, and David J. Sugarbaker Malignant pleural mesothelioma (MPM) is a rare but highly
MESOTHELIOMA. Not Just a Late Night Commercial. Graciela Hoal, RN, MSN, ACNP-BC
MESOTHELIOMA Not Just a Late Night Commercial Graciela Hoal, RN, MSN, ACNP-BC Saturday Session Thoracic Surgery Nurse Practitioner Greater Los Angeles Veteran Affairs Objectives Course Objectives: Discuss
Treatment of Mesothelioma with Radiotherapy
41 Treatment of Mesothelioma with Radiotherapy Ryan P. Smith and Stephen M. Hahn General Principles of Radiation Therapy Radiation therapy is a therapeutic modality that uses ionizing radiation to treat
Surgical Management of Malignant Pleural Mesothelioma: A Clinical Practice Guideline
Evidence-based Series #7-14-2: Section 1 Surgical Management of Malignant Pleural Mesothelioma: A Clinical Practice Guideline D.E. Maziak, A. Gagliardi, A.E. Haynes, J.A. Mackay, W.K. Evans, and members
MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology
MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image
Surgical therapy of. who should be operated
SAMO Interdisciplinary Workshop on Chest Tumors Lucerne, 13th and 14th January 2012 Surgical therapy of mesothelioma, who should be operated Walter Weder MD Professor of Surgery University Hospital Zurich
Malignant Pleural Mesothelioma in Singapore
RESEARCH COMMUNICATION C SP Yip 1, HN Koong 2, CM Loo 3, KW Fong 1* Abstract Aim: To examine the clinical characteristics and outcomes of malignant pleural mesothelioma (MPM) in Singapore. Methods and
L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
Choosing a Clinical Trial for Advanced Mesothelioma
Choosing a Clinical Trial for Advanced Mesothelioma RN Taub (Onc) J Chabot (Surg) A Borczuk (Path) J Sonnet (Surg) M Kluger (Surg) R Fawwaz (Nuc. Med) E Hare (Onc) Columbia University Mesothelioma Center
Malignant pleural mesothelioma P/D vs. EPP
3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy
Small Cell Lung Cancer
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
SMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
Post-operative intrapleural chemotherapy for mesothelioma
Post-operative intrapleural chemotherapy for mesothelioma Robert Kratzke, MD John Skoglund Chair for Lung Cancer Research Section of Heme-Onc-Transplant University of Minnesota Medical School Efficacy
III. EXTENT OF DISEASE
Advanced Abstracting Lung Cancer III. EXTENT OF DISEASE Staging Systems and Documentation 1 Source: AJCC Cancer Staging Illustrations from the AJCC Cancer Staging Atlas. Springer, 2007. Used with permission.
It was estimated that 2200 to 3000 new cases of mesothelioma
RESECTION MARGINS, EXTRAPLEURAL NODAL STATUS, AND CELL TYPE DETERMINE POSTOPERATIVE LONG-TERM SURVIVAL IN TRIMODALITY THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA: RESULTS IN 183 PATIENTS David J. Sugarbaker,
Recommendations for the Reporting of Pleural Mesothelioma
Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports
Administrative. Patient name Date compare with previous Position markers R-L, upright, supine Technical quality
CHEST X-RAY Administrative Patient name Date compare with previous Position markers R-L, upright, supine Technical quality AP or PA ( with x-ray beam entering from back of patient, taken at 6 feet) Good
FATAL PNEUMONITIS ASSOCIATED WITH INTENSITY-MODULATED RADIATION THERAPY FOR MESOTHELIOMA
RAPID COMMUNICATION FATAL PNEUMONITIS ASSOCIATED WITH INTENSITY-MODULATED RADIATION THERAPY FOR MESOTHELIOMA AARON M. ALLEN, M.D.,* MARIA CZERMINSKA, M.S.,* PASI A. JÄNNE, M.D., PH.D., DAVID J. SUGARBAKER,
B. Dingle MD, FRCPC, Brian Yaremko MD,FRCPC, R. Ash, MD, FRCPC, P. Truong, MD, FRCPC
Lung Cancer B. Dingle MD, FRCPC, Brian Yaremko MD,FRCPC, R. Ash, MD, FRCPC, P. Truong, MD, FRCPC EPIDEMIOLOGY The estimated incidence of lung cancer in Canada for 2007 is 23,300 with 12,400 occurring in
Understanding Pleural Mesothelioma
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
Primary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
Mesothelioma: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
Minimally Invasive Spine Surgery
Chapter 1 Minimally Invasive Spine Surgery 1 H.M. Mayer Primum non nocere First do no harm In the long history of surgery it always has been a basic principle to restrict the iatrogenic trauma done to
Progress in Radical Surgery for Malignant Pleural Mesothelioma
Send Orders for Reprints to [email protected] 10 The Open Cardiovascular and Thoracic Surgery Journal, 2013, 6, 10-15 Progress in Radical Surgery for Malignant Pleural Mesothelioma Leonardo Politi
Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer
Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer Dan Vogl Lay Abstract Early stage non-small cell lung cancer can be cured
Management of Chest Tubes and Air Leaks after Lung Resection
Management of Chest Tubes and Air Leaks after Lung Resection Emily Kluck PA-C The Johns Hopkins Hospital Baltimore, MD AATS 2014, Toronto, CAN April 2014 Management of Chest Tubes 1 Overview Review the
Lung Cancer Treatment Guidelines
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
UNMH Cardiothoracic Surgery Clinical Privileges
All new applicants must meet the following requirements as approved by the UNMH Board of Trustees effective: 02/20/2015 INSTRUCTIONS Applicant: Check off the "Requested" box for each privilege requested.
Current Status and Perspectives of Radiation Therapy for Breast Cancer
Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic
Update on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
Characteristics of Malignant Pleural Mesothelioma in Women
Characteristics of Malignant Pleural Mesothelioma in Women Andrea S. Wolf, MD, MPH, William G. Richards, PhD, Tamara R. Tilleman, MD, PhD, Lucian Chirieac, MD, Shelley Hurwitz, PhD, Raphael Bueno, MD,
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); [email protected] Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
Therapy of pleural effusions Modern techniques
Therapy of pleural effusions Modern techniques Dr. Melanie Toffel Sugery of the chest Pleural effusion Ethiology In the normal pleural space there is a steady state in which there is a roughly equal rate
Surgical treatment for malignant pleural mesothelioma: extrapleural pneumonectomy, pleurectomy/decortication or extended pleurectomy?
JBUON 2015; 20(2): 376-380 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: [email protected] REVIEW ARTICLE Surgical treatment for malignant pleural mesothelioma: extrapleural pneumonectomy,
PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande
PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY Dr. Shailesh V. Shrikhande Associate Professor & Consultant Surgeon GI and HPB Surgical Oncology Tata Memorial Hospital, Mumbai INDIA HELICAL
Practical class 3 THE HEART
Practical class 3 THE HEART OBJECTIVES By the time you have completed this assignment and any necessary further reading or study you should be able to:- 1. Describe the fibrous pericardium and serous pericardium,
Protocol for the Examination of Specimens From Patients With Malignant Pleural Mesothelioma
Protocol for the Examination of Specimens From Patients With Malignant Pleural Mesothelioma Based on AJCC/UICC TNM, 7th edition Protocol web posting date: February 1, 2011 Procedures Resection Authors
An Introduction to Anatomy and Physiology
An Introduction to Anatomy and Physiology Objectives Define anatomy and physiology Identify the levels of organization in organisms from simplest to most complex Identify the organ systems of the human
Radiation Therapy in the Treatment of
Lung Cancer Radiation Therapy in the Treatment of Lung Cancer JMAJ 46(12): 537 541, 2003 Kazushige HAYAKAWA Professor and Chairman, Department of Radiology, Kitasato University School of Medicine Abstract:
The Need for Accurate Lung Cancer Staging
The Need for Accurate Lung Cancer Staging Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 115th Annual Convention Financial Disclosures: None 2 Objectives
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year
Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital*
13 Original Article Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital* Ricardo Mingarini Terra 1, Lisete Ribeiro Teixeira 2, Ricardo Beyruti 1, Teresa Yae Takagaki
1) Thoracic Surgery, Kyoto University Hospital. 2) Radiation Oncology and Image-Applied Therapy, Kyoto University Hospital
Title Survival and relapse pattern after malignant pleural mesothelioma. Okubo, Kenichi; Sonobe, Makoto; Fuj Author(s) Tsuyoshi; Sakai, Hiroaki; Miyahara, Hiroshi; Shibuya, Keiko; Hiraoka, M Citation General
Radiotherapy in locally advanced & metastatic NSC lung cancer
Radiotherapy in locally advanced & metastatic NSC lung cancer Dr Raj Hegde. MD. FRANZCR Consultant Radiation Oncologist. William Buckland Radiotherapy Centre. Latrobe Regional Hospital. Locally advanced
How To Treat Lung Cancer At Cleveland Clinic
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
Thoracoscopy in Pleural Malignant Mesothelioma
Diagnostic and Therapeutic Endoscopy, 1997, Vol. 3, pp. 147-151 Reprints available directly from the publisher Photocopying permitted by license only (C) 1997 OPA (Overseas Publishers Association) Amsterdam
Results of Surgery in a New Lung Institute in South Texas Focused on the Treatment of Lung Cancer
Results of Surgery in a New Lung Institute in South Texas Focused on the Treatment of Lung Cancer Lung cancer accounts for 13% of all cancer diagnoses and is the leading cause of cancer death in both males
Summary of treatment benefits
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
CHAPTER 1: THE LUNGS AND RESPIRATORY SYSTEM
CHAPTER 1: THE LUNGS AND RESPIRATORY SYSTEM INTRODUCTION Lung cancer affects a life-sustaining system of the body, the respiratory system. The respiratory system is responsible for one of the essential
Induction of Apoptosis by Intrapleural Perfusion Hyperthermo-Chemotherapy for Malignant Pleural Mesothelioma
Original Article Induction of Apoptosis by Intrapleural Perfusion Hyperthermo-Chemotherapy for Malignant Pleural Mesothelioma Yasunori Matsuzaki, MD, Masaki Tomita, MD, Tetsuya Shimizu, MD, Masaki Hara,
How To Understand How Cancer Works
Mesothelioma Understanding your diagnosis Mesothelioma Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount of
Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma
Disease Markers Volume 2015, Article ID 282145, 5 pages http://dx.doi.org/10.1155/2015/282145 Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Emanuela Taioli,
Principal Investigator: Valerie W. Rusch, MD, FACS, Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center
Protocol 1101-1088 Phase I study of intra-pleural administration of GL-ONC1 in patients with malignant pleural effusion: primary, metastases and mesothelioma Principal Investigator: Valerie W. Rusch, MD,
Brigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA
Determination of Biomarker Response in a Phase II Window of Opportunity Study of Defactinib (VS 6063), a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Resectable Malignant Pleural Mesothelioma
Radical surgery for malignant pleural mesothelioma: results and prognosis
doi:10.1510/icvts.2007.166322 Interactive CardioVascular and Thoracic Surgery 7 (2008) 102 106 www.icvts.org Institutional report - Thoracic general Radical surgery for malignant pleural mesothelioma:
Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer About Your Lungs and Lung Cancer How do your lungs work? To understand lung cancer it is helpful to understand your lungs. Your lungs put oxygen into the blood, which the heart
Calculation of Contra-lateral Lung Doses in Thoracic IMRT: An Experimental Evaluation
Calculation of Contra-lateral Lung Doses in Thoracic IMRT: An Experimental Evaluation Deborah Schofield, Laurence Court, Aaron Allen, Fred Hacker, Maria Czerminska Department of Radiation Oncology Dana
Malignant Mesothelioma
Malignant Mesothelioma What is malignant mesothelioma? Malignant mesothelioma is a cancer that starts in cells in the linings of certain parts of the body, especially in the linings of the chest or abdomen.
Screening, early referral and treatment for asbestos related cancer
Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto Asbestos related diseases Mesothelioma Lung
Contemporary Management of Malignant Pleural Mesothelioma
Contemporary Management of Malignant Pleural Mesothelioma ERIC G. BUTCHART University Hospital of Wales, Cardiff, United Kingdom Key Words. Mesothelioma Surgery Radiotherapy Chemotherapy Immunology Gene
Analysis of the effect of radiotherapy on malignant pleural mesothelioma when given on adjuvant or palliative basis
Analysis of the effect of radiotherapy on malignant pleural mesothelioma when given on adjuvant or palliative basis Hesham A. El Hossieny, MD 1, Fatma Aboulkasem, MD 2, Abdel Rahman M.,MD 3. (1) Department
NEEDLE THORACENTESIS Pneumothorax / Hemothorax
NEEDLE THORACENTESIS Pneumothorax / Hemothorax By: Steven Jones, NREMT-P Pneumothorax Pneumothorax is a collection of air or gas in the pleural space of the lung, causing the lung to collapse. Pneumothorax
